Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.30 | N/A |
| PEG Ratio (TTM) | -0.13 | N/A |
| P/S Ratio (TTM) | 0.08 | N/A |
| P/B Ratio (TTM) | 1.21 | N/A |
| P/FCF Ratio (TTM) | -2.69 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -17.81% | N/A |
| ROE (TTM) | -72.59% | N/A |
| Net Profit Margin (TTM) | -6.12% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 8.38% | 83.05% | N/A |
| Revenue | -1.95% | 39.72% | N/A |
| Net Income | 8.10% | 41.90% | N/A |
| Cash Flow | -501.79% | -163.90% | N/A |
Health (16%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.23 | N/A |
| Quick Ratio (TTM) | 0.25 | N/A |
| D/E Ratio (TTM) | 3.88 | N/A |
| Interest Coverage (TTM) | -2.21 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 1.07 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |